Vav Life Sciences Private Limited, a active private limited company, was established on 16 January 2003 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230MH2003PTC138713. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.20 Cr and a paid-up capital of ₹1.20 Cr.
It upholds a compliant status. Its leadership includes Arun Radheshyam Kedia (Director), Sabita Kedia (Director). Past directors included Pritma Amol Deshpande, Joggy George Premadikuzhiyil, Amit Ashok Pimpale. It holds ₹3.00 Cr open charges and ₹8.13 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 51-B Mittal Courtnariman Point, Mumbai, Maharashtra, 400021.
U24230MH2003PTC138713
138713
16 January 2003
₹1.20 Cr
₹1.20 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Vav Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arun Radheshyam Kedia | Director | 16 Jan 2003 | Current |
| Sabita Kedia | Director | 29 Jul 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Aug 2013 | Past |
| Pramod Abcsdd | Director | 09 Feb 2018 | Past |
| Pramod Abcsdd | Director | 16 Feb 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vav Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.91% increase. The company also saw a substantial improvement in profitability, with a 13.87% increase in profit. The company's net worth moved up by a moderate rise of 7.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Vav Life Sciences had a promoter holding of 60.00% and a public holding of 40.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹30,000,000.00
₹81,328,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2024 | Others | ₹3.00 Cr | Open |
| 29 May 2019 | Axis Bank Limited | ₹2.65 Cr | Satisfied |
| 28 May 2019 | Axis Bank Limited | ₹4.00 M | Satisfied |
| 08 Dec 2009 | Bank Of India | ₹3.20 Cr | Satisfied |
| 03 Jul 2008 | Bank Of India | ₹9.83 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vav Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vav Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vav Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 101047631 was registered on 25 Oct 2024. was recorded as a recent event.
Vav Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Vav Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge registered on 29 May 2019 via Charge ID 100365692 with Axis Bank Limited was fully satisfied on 06 Mar 2023. was documented.
A charge registered on 28 May 2019 via Charge ID 100365694 with Axis Bank Limited was fully satisfied on 06 Mar 2023. was recorded as a recent event.
The activity A charge registered on 08 Dec 2009 via Charge ID 10197798 with Bank Of India was fully satisfied on 17 Aug 2019. was completed.
India Business News: Mumbai, Jan 31 () One of the top phospholipid manufacturers, VAV Life Sciences inaugurated its cGMP compliant phospholipid manufacturing plant in Mirj.
The CIN of Vav Life Sciences Private Limited is U24230MH2003PTC138713.
Vav Life Sciences Private Limited is headquartered at 51-B Mittal Courtnariman Point, Mumbai, Maharashtra, 400021.
Vav Life Sciences Private Limited was incorporated on 16 January 2003.
The current directors of Vav Life Sciences Private Limited are
The primary industry of Vav Life Sciences Private Limited is Manufacturing.
Vav Life Sciences Private Limited is unlisted.
The authorized capital of Vav Life Sciences Private Limited is ₹1.20 Cr, and the paid-up capital is ₹1.20 Cr.
The compliance status of Vav Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX